ATE459365T1 - Verfahren zur behandlung von entzündungserkrankungen mit maracujaextrakten - Google Patents

Verfahren zur behandlung von entzündungserkrankungen mit maracujaextrakten

Info

Publication number
ATE459365T1
ATE459365T1 AT07251879T AT07251879T ATE459365T1 AT E459365 T1 ATE459365 T1 AT E459365T1 AT 07251879 T AT07251879 T AT 07251879T AT 07251879 T AT07251879 T AT 07251879T AT E459365 T1 ATE459365 T1 AT E459365T1
Authority
AT
Austria
Prior art keywords
maracuja
extracts
inflammatory diseases
treating inflammatory
extract
Prior art date
Application number
AT07251879T
Other languages
English (en)
Inventor
Lai Yeap Foo
Yinrong Lu
Ronald Ross Watson
Original Assignee
Ind Res Ltd L L C
Southwest Scient Editing & Con
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Res Ltd L L C, Southwest Scient Editing & Con filed Critical Ind Res Ltd L L C
Application granted granted Critical
Publication of ATE459365T1 publication Critical patent/ATE459365T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
AT07251879T 2006-05-04 2007-05-04 Verfahren zur behandlung von entzündungserkrankungen mit maracujaextrakten ATE459365T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/417,721 US20060280821A1 (en) 2005-04-04 2006-05-04 Method of treating inflammation disorders using extracts of passion fruit

Publications (1)

Publication Number Publication Date
ATE459365T1 true ATE459365T1 (de) 2010-03-15

Family

ID=38319569

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07251879T ATE459365T1 (de) 2006-05-04 2007-05-04 Verfahren zur behandlung von entzündungserkrankungen mit maracujaextrakten

Country Status (8)

Country Link
US (1) US20060280821A1 (de)
EP (1) EP1854470B8 (de)
JP (1) JP4813418B2 (de)
AT (1) ATE459365T1 (de)
CA (1) CA2587126C (de)
DE (1) DE602007005041D1 (de)
ES (1) ES2342018T3 (de)
NZ (1) NZ554762A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5347018B2 (ja) * 2009-04-03 2013-11-20 森永製菓株式会社 ピセアタンノール含有組成物及びピセアタンノール含有組成物の製造方法
EP2585086B1 (de) 2010-06-28 2017-08-09 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Neuroprotektiver natürlicher passionsfrucht-extrakt
JP6356492B2 (ja) * 2014-05-28 2018-07-11 森永製菓株式会社 抗炎症剤
CN104397621A (zh) * 2014-12-12 2015-03-11 广西职业技术学院 西番莲果皮罐头
KR101976202B1 (ko) 2017-10-23 2019-05-08 안동대학교 산학협력단 패션후르츠 과피 추출물을 유효성분으로 함유하는 혈전증의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품
KR102254421B1 (ko) 2017-12-05 2021-05-20 성화정 패션후르츠 과육과 씨의 혼합 추출물을 유효성분으로 함유하는 혈전증의 예방 또는 치료용 약학적 조성물 및 건강 기능 식품
JP7642299B2 (ja) * 2018-05-09 2025-03-10 森永製菓株式会社 パッションフルーツ種子の抽出物を有効成分とする発毛促進剤、医薬、食品および化粧品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
JPH01172325A (ja) * 1987-12-28 1989-07-07 Terumo Corp 抗リウマチ剤
JP3362494B2 (ja) * 1994-03-01 2003-01-07 三菱ウェルファーマ株式会社 ベンゾオキサジン化合物
US6544581B1 (en) * 1999-06-22 2003-04-08 Canandaigua Wine Company, Inc. Process for extraction, purification and enrichment of polyphenolic substances from whole grapes, grape seeds and grape pomace
US6818234B1 (en) * 1999-08-27 2004-11-16 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
US6605306B1 (en) * 2002-07-01 2003-08-12 Lonny S. Green Food supplement formulation
US6555142B1 (en) * 2002-07-01 2003-04-29 Lonny S. Green Food supplement formulation
EP1763360A4 (de) 2004-04-02 2009-08-19 Ind Res Ltd L L C Extrakte aus der passionsfrucht und ihre verwendungen

Also Published As

Publication number Publication date
JP4813418B2 (ja) 2011-11-09
EP1854470A1 (de) 2007-11-14
CA2587126A1 (en) 2007-11-04
US20060280821A1 (en) 2006-12-14
DE602007005041D1 (de) 2010-04-15
CA2587126C (en) 2013-04-09
EP1854470B1 (de) 2010-03-03
JP2007302659A (ja) 2007-11-22
ES2342018T3 (es) 2010-06-30
EP1854470B8 (de) 2010-05-19
NZ554762A (en) 2008-12-24

Similar Documents

Publication Publication Date Title
ATE459365T1 (de) Verfahren zur behandlung von entzündungserkrankungen mit maracujaextrakten
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
WO2007128761A3 (de) Verwendungen von dpp iv inhibitoren
DK1970059T3 (da) Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser
WO2010070675A8 (en) Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
WO2006003388A3 (en) Compositions and methods for treating inflammatory disorders
WO2007092556A3 (en) Method of using abscisic acid to treat and prevent diseases and disorders
MY156316A (en) Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products
WO2008042174A3 (en) Mesenchymal stem cells and uses therefor
WO2008096203A3 (en) Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders
DE60228235D1 (de) Tiernahrungszusammensetzung zur verbesserung der haut
WO2006033734A3 (en) Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders
WO2009048778A3 (en) Laminins, derivatives, and compositions including same and method for their therapeutic use
WO2007098142A3 (en) Oxazole ketones as modulators of fatty acid amide hydrolase
BRPI0616982B8 (pt) uso de oligouronato, composição farmacêutica inalável e aplicador de spray
GT200600115A (es) Metodo para identificar blancos terapeuticos para el tratamiento de atrofia vulvoginal
WO2007087424A3 (en) Method of treating kcnq related disorders using organozinc compounds
EP1844779A3 (de) Tergurid/Protergurid zur Behandlung von chronischen Schmerzen (z.B. Migräne)
WO2007106909A3 (en) Method of using pomegranate extracts for increasing prostate specific antigen doubling time
WO2008067056A3 (en) Method of inhibiting coagulation with human anti-factor va antibodies and use thereof
WO2007108004A8 (en) S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
WO2006079068A3 (en) Compositions and methods for studying and treating inflammatory diseases and disorders
DE502005010502D1 (de) Pharmazeutische Zusammensetzung, Verwendung dieser pharmazeutischen Zusammensetzung zur Herstellung eines Medikaments und/oder eines Nahrungsergänzungmittels zur Behandlung von Übergewicht und/oder Symptomen, die mit Übergewicht einhergehen, beim Menschen oder Säugetier, sowie Verfahren zur Herstellung dieser pharmazeutischen Zusammensetzung
ATE473277T1 (de) Zusammensetzungen und verfahren zur prävention und behandlung von immunvermittelten entzündungskrankheiten
DE602004003173D1 (de) Verwendung von konjugierter Linolsäure zur Behandlung der Erkältung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties